BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 17718245)

  • 21. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
    Ni SS; Gao ZL
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
    Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
    Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiology and prognostic significance of massive pleural effusions.
    Jiménez D; Díaz G; Gil D; Cicero A; Pérez-Rodríguez E; Sueiro A; Light RW
    Respir Med; 2005 Sep; 99(9):1183-7. PubMed ID: 16085221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.
    Okamoto M; Kawabe T; Iwasaki Y; Hara T; Hashimoto N; Imaizumi K; Hasegawa Y; Shimokata K
    J Lab Clin Med; 2005 Feb; 145(2):88-93. PubMed ID: 15746651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.
    Sarandakou A; Poulakis N; Rizos D; Phocas I
    Anticancer Res; 1991; 11(3):1365-8. PubMed ID: 1888173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of c-c chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
    Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
    Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis.
    Garcia-Pachon E; Soler MJ; Padilla-Navas I; Romero V; Shum C
    Respiration; 2005; 72(5):486-9. PubMed ID: 16210887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL22 is involved in the recruitment of CD4+CD25 high T cells into tuberculous pleural effusions.
    Wu C; Zhou Q; Qin XJ; Qin SM; Shi HZ
    Respirology; 2010 Apr; 15(3):522-9. PubMed ID: 20337996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When pleural potassium exceeds 5.0 mEq/L, high pleural adenosine deaminase levels do not necessarily indicate tuberculous pleuritis.
    Kashiwabara K; Okamoto T; Yamane H
    Respirology; 2012 Jan; 17(1):92-8. PubMed ID: 21883680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
    Liam CK; Lim KH; Wong CM
    Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunoassay determinations of prostaglandin E in pleural effusions of varying causes.
    Jenkinson SG; Banschbach MW
    Am Rev Respir Dis; 1982 Jul; 126(1):21-4. PubMed ID: 7091905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
    Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
    Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of CYFRA21-1, Scc-Ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer.
    Liu L; Liu B; Zhu LL; Zhang W; Li Y
    Bioanalysis; 2012 Oct; 4(19):2367-74. PubMed ID: 23088463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of telomerase activity in bronchoscopic brush-off samples in patients with lung cancer].
    Yan YL; Zheng JX; Wang X; Wang Y; Yang JY
    Ai Zheng; 2002 Jul; 21(7):768-71. PubMed ID: 12479104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion.
    Elsammak M MY; Morsi TS; Khamis HI; Ragab MS; Zaki MA; Abdel-Hadi M; Hassan HA
    Ann Clin Biochem; 2007 May; 44(Pt 3):264-72. PubMed ID: 17456294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase activity in benign and malignant cytologic fluids.
    Mu XC; Brien TP; Ross JS; Lowry CV; McKenna BJ
    Cancer; 1999 Apr; 87(2):93-9. PubMed ID: 10227600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic significance of gamma-interferon in tuberculous pleurisy.
    Poyraz B; Kaya A; Ciledağ A; Oktem A; Gönüllü U
    Tuberk Toraks; 2004; 52(3):211-7. PubMed ID: 15351932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.